Invert Graphite Limited has released a press release.
Shareholder Update
Filed with ASX ·
6ix hasn’t read this filing yet.
Invert Graphite Limited on 6ix
Earlier from Invert Graphite
- Factor receives $3.1M R&D tax rebate
- 50% recruitment reached in VF00102 Clinical Trial
- Appendix 4C for the September Quarter
- Shareholder communication - clinical trial update
- Appendix 4E and Full Year Statutory Accounts
Later from Invert Graphite
- Appendix 4C - December 2017 Quarter
- Appendix 4E Preliminary Final Report
- Rights Issue Entitlement Offer Information Booklet
- Clinical Trial update - March quarter
- Appendix 4C - March 2018 Quarter
Follow Invert Graphite into a list and get an email when it puts out news.
Follow Invert Graphite